Back to search

Article

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells

2020-01-30

Abstract excerpt

Failed T cell-based immunotherapies in the presence of genomic alterations in antigen presentations pathways may be overcome by NK cell-based immunotherapy. This approach may still be limited by the presence of immunosuppressive myeloid populations. Here we demonstrate that NK cells (haNKs) engineered to express a PD-L1 chimeric antigen receptor (CAR) haNKs killed a panel of human and murine head and neck cancer c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a284975e-ae1d-59d3-a381-646a629d60ed
DOI
10.1101/2020.01.30.926535
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cellsDOI 10.1101/2020.01.30.926535
Select a neighboring publication to make it the new centre.